Navigation Links
Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
Date:3/31/2008

to continue as a "going concern."

Commenting further, Andrews said, "Given the current uncertainty surrounding the credit markets and our need for access to working capital to support our continued rapid growth, we were pleased to gain access to the capital necessary to enable us to continue to execute our plan. The new Safeguard credit line, along with our renewed facility with Comerica Bank, puts us on solid financial footing from which we can embark on the launch of our new breast cancer test. Based on our improvement in gross margins in 2007, our current commercial growth and our ongoing expense management, we believe we should be able to reduce our operating losses during 2008, which in turn should reduce the amount of additional funds we will need to draw from our newly negotiated line of credit."

The financial results described above reflect the impact of the adjustment to bad debt expense described above, as well as an aggregate $950,000 adjustment to reduce revenue (and record a corresponding liability) that the Company has made to its consolidated financial statements (allocated over a period of multiple quarters) resulting from the Company's analysis of financial information provided to the Company from its third party billing vendor relating to certain credit balances. As a result of matters identified in connection with the Company's year-end financial statement preparation process, management has identified material weaknesses in the Company's internal control over financial reporting. Additional details relating to these material weaknesses and the above-referenced adjustments will be included in the Company's Form 10-K for the fiscal year ended December 31, 2007 to be filed with the Securities and Exchange Commission.

Clarient will discuss fourth quarter 2007 results and certain future expectations on a conference call and live web cast at 8:00 a.m. EDT today. Call information is available at

SOURCE Clarient, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Clarient to Commercialize Novel Breast Cancer Profile
3. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... Cuvettes have been used in countless labs for decades. In the past, people had ... As expected, this was a daunting and tiring process looking at endless data tables and ... to navigate the complex catalog structure. , Now thanks to FireflySci, scientists are throwing away ...
(Date:7/2/2015)... , July 2, 2015 Amici ... Bio-tech procurement company Amici Procurement has chosen Microsoft Cloud ... it move to Office 365.      (Logo: ... small to medium-sized companies in the bio-tech sector with ... of the purchasing cycle to help them obtain best ...
(Date:7/1/2015)... ... , ... It is now possible to separate two common disorders: post-traumatic stress ... (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, and University ... believed to be the largest brain imaging study ever, will be published on July ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical ... segments, including the molecular diagnostics industry. BCC Research reveals in its new report that ... lower test costs, and a growing need for better diagnostics as part of a ...
Breaking Biology Technology:New Cuvette E-Commerce Website Launched by FireflySci 2Biotech Procurement Company Moves to Office 365 with iomart 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3
... July 9 Human Genome Sciences, Inc. (Nasdaq: ... New England Journal of Medicine of the ... life-saving potential of the Company,s human monoclonal antibody drug raxibacumab ... which supported the use of raxibacumab in the event of ...
... gene that is essential for embryonic stem cells to ... may lead to a greater understanding of how cells ... efficiently reprogram mature cells back into the pluripotent state, ... crucial to a range of potential clinical treatments. ...
... July 8 Intellikine, Inc., a leader in the ... of cancer, inflammation and autoimmune diseases, announced today that ... Novartis Bioventures Ltd. led the financing in which ... FinTech Global Capital participated. Markus Goebel, M.D., Ph.D., ...
Cached Biology Technology:Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax 2Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax 3Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax 4Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax 5Stem cells' 'suspended' state preserved by key step, scientists report 2Stem cells' 'suspended' state preserved by key step, scientists report 3Intellikine Completes $51 Million Financing 2
(Date:6/24/2015)... , June 24, 2015 This report provides ... the next six years. It contains an analysis of ... along with their impact from the short, medium, and ... discusses the industry, market, and technology trends that currently, ... need of concerned authorities to efficiently manage the increasing ...
(Date:6/24/2015)... , June 24, 2015 Biometry ... with emerging biometric password solution one face in. ... one face in, entering the ... ground-breaking and affordable multifactor-authentication biometric answer to the ... technology, provided in partnership with KeyLemon, one face ...
(Date:6/23/2015)... , June 23, 2015   Valencell, ... the results of a recent study that illustrates ... the wrist during activity. In a study conducted ... compared along with the Apple Watch against a ... heart rate during activity. The study demonstrated that ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... Orangutans threatened with extinction could be brought back from ... Technology (QUT) statistician. Professor Kerrie Mengersen, from the ... to guide efforts for saving the Indonesian primate whose ... said the study had found a quarter of villagers ...
... Ore. An international group of scientists from the ... collaborating on a fascinating new climate modeling initiative ... create a network of digital power that surpasses that ... initial effort in 2003 and its "climateprediction.net" project has ...
... and neck cancer who have never smoked have much better ... of smoking, new research from UC Davis Cancer Center ... colleagues in the UC Davis radiation oncology and otolaryngology departments ... differences based on smoking history in patients with head and ...
Cached Biology News:Orangutans count on stats for survival 2OSU, Oxford, others launch citizen scientist climate modeling initiative 2OSU, Oxford, others launch citizen scientist climate modeling initiative 3Never-smokers fare far better than smokers after radiation therapy for head and neck cancer 2
... one mouse-click image analysis software for ... is the solution for high quality ... MicroVigene is empowered with VigeneTechs robust ... regional 2D-curve fitting background correction and ...
... System, Professional Package Superior Protein Detection ... The ProXPRESS 2D Proteomic Imaging System is ... both proteomic and general life science research ... the use of all dyes in the ...
... Fibroblasts (rabbit) and media. Cryo-preserved cells in ... at passage 25 (approx), supplied with kit ... is supplied as a long-term culture, and ... months of continuous growth from the date ...
... Spike-In Kit contains in vitro synthesized, polyadenylated ... control probes on Agilents microarrays, with minimal ... a positive microarray control in the hybridization ... is a required component of the Agilent ...
Biology Products: